Korea’s Biopharma Policies Put To Test Amid Political Turmoil
Discontinuity Concerns Raised
A short-lived but shocking attempt to declare martial law by South Korea's president has thrown the country into political turmoil which could disrupt foreign biopharma investment and key policy initiatives.
